EQS-News: Immunic to Participate in Investor and Scientific Conferences in November and December

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Investor and Scientific Conferences in November and December 10.11.2022 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Investor and Scientific Conferences ...

Related Keywords

Germany ,New York ,United States ,Australia ,Munich ,Bayern ,Perth ,Western Australia ,Russia ,Adelaide ,South Australia ,Ukraine ,Franziska Buri ,Lawrence Steinman ,Edna Kaplan ,Heinz Wiendl ,Thomas Polasek ,Inge Kehler ,Andreas Muehler ,Hella Kohlhof ,Paula Schwartz ,Thomasm Polasek ,Evelyn Peelen ,Daniel Vitt ,Juliano Fonseca ,Jessica Breu ,Jelena Mihajlovic ,Jelena Mihajlovi ,Fredd Lublin ,Institute Of Translational Neurology ,Department Of Neurology ,University Of Mu ,Stanford University School Of Medicine ,Rx Communications Group ,Distribution Services ,Nasdaq ,Australasian Society Of Clinical ,Department Of Neurology Neurological Sciences ,Australasian Pharmaceutical Science Association ,Corinne Goldsmith Dickinson Center ,Neurological Sciences ,Exchange Commission ,Clinical Operations Program Lead At Immunic ,Piper Sandler Co ,Icahn School Of Medicine ,Immunic Inc ,Scientific Conferences ,Saunders Family Professor ,Multiple Sclerosis ,Icahn School ,Mount Sinai Hospital ,Stanford University School ,Director Department ,Translational Neurology ,Piper Sandler ,Annual Healthcare ,Chief Executive Officer ,Australasian Society ,Experimental Pharmacologists ,Clinical Pharmacology Registrar ,Royal Adelaide Hospital ,Tight Junction Regulator ,Amelie Schreieck ,Clinical Trials ,Clinical Operations Program Lead ,Clinical Operations ,Private Securities Litigation Reform Act ,Annual Report ,Investor Relations ,Corporate News ,Regulatory Announcements ,Key ,Conference ,Immunic ,Articipate ,Investor ,Cientific ,Conferences ,November ,December ,Et Cest ,The ,